Skip to main content

Class C — Medium-High Risk

Definition and Scope

Class C devices present a medium to high risk and require an enhanced registration dossier with substantive clinical evidence and robust conformity assessment. These are typically long-term invasive devices or devices supplying significant energy to the body.

Classification Criteria

A device is typically Class C when it:

  • Is a long-term invasive device (implanted for > 30 days) other than Class D
  • Is active and intended to diagnose, monitor, or supply energy for therapeutic purposes in a potentially hazardous manner
  • Delivers ionising radiation
  • Has a biological effect (e.g. bioresorbable implants)
  • Is intended for use in direct cardiac contact (non-Class D)
  • Is a blood bag or central vascular catheter

Class C Examples

ProductNotes
Long-term urinary catheters (>30 days)Long-term invasive
Bone fixation plates and screwsLong-term implantable
Haemodialysis systemsExtracorporeal blood circuit
Lung ventilatorsLife-supporting but not Class D
Diagnostic X-ray machinesDelivers ionising radiation
Drug infusion pumpsActive, life-sustaining adjacent
Intraocular lenses (IOLs)Long-term implantable
Vascular grafts (non-cardiac)Long-term implantable
Mammography systemsIonising radiation diagnostic
Infusion pumpsActive, medication delivery

Registration: Enhanced Dossier

In addition to all Class B requirements, Class C dossiers must include:

Enhanced Technical Documentation

  • Full risk management file (ISO 14971) — not just summary
  • Complete clinical evaluation report (CER) per GHTF SG5/IMDRF MDCE WG
  • Post-market clinical follow-up (PMCF) plan
  • Summary of safety and performance (SSP) if available

Clinical Evidence Requirements

  • Clinical data from clinical investigations and/or literature
  • Demonstration of clinical benefit
  • Acceptable benefit-risk profile
  • Equivalence justification (if relying on equivalent device data)

Conformity Assessment

  • ISO 13485 QMS certificate
  • Third-party review of technical documentation by a recognised Conformity Assessment Body (CAB) for Class C

Processing Timeline

Target: 120 working days from acceptance of complete application.

Clinical Data is Critical

MDA scrutinises clinical evidence for Class C devices carefully. Insufficient clinical data is a leading cause of rejections. Ensure your Clinical Evaluation Report is comprehensive, current, and product-specific.